BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 15507622)

  • 1. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors.
    Sandalon Z; Bruckheimer EM; Lustig KH; Rogers LC; Peluso RW; Burstein H
    J Virol; 2004 Nov; 78(22):12355-65. PubMed ID: 15507622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term suppression of experimental arthritis following intramuscular administration of a pseudotyped AAV2/1-TNFR:Fc Vector.
    Sandalon Z; Bruckheimer EM; Lustig KH; Burstein H
    Mol Ther; 2007 Feb; 15(2):264-9. PubMed ID: 17235303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
    Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts.
    McTiernan CF; Mathier MA; Zhu X; Xiao X; Klein E; Swan CH; Mehdi H; Gibson G; Trichel AM; Glorioso JC; Feldman AM; McCurry KR; London B
    Gene Ther; 2007 Dec; 14(23):1613-22. PubMed ID: 17851548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of repeat transduction by recombinant adeno-associated virus type 5/5 vectors in the mouse airway.
    Sumner-Jones SG; Gill DR; Hyde SC
    J Virol; 2007 Nov; 81(22):12360-7. PubMed ID: 17855531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.
    Adriaansen J; Khoury M; de Cortie CJ; Fallaux FJ; Bigey P; Scherman D; Gould DJ; Chernajovsky Y; Apparailly F; Jorgensen C; Vervoordeldonk MJ; Tak PP
    Ann Rheum Dis; 2007 Sep; 66(9):1143-50. PubMed ID: 17363402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural administration of a serotype 5 adeno-associated virus coding for alpha1-antitrypsin mediates persistent, high lung and serum levels of alpha1-antitrypsin.
    De B; Heguy A; Leopold PL; Wasif N; Korst RJ; Hackett NR; Crystal RG
    Mol Ther; 2004 Dec; 10(6):1003-10. PubMed ID: 15564132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
    Auricchio A; O'Connor E; Weiner D; Gao GP; Hildinger M; Wang L; Calcedo R; Wilson JM
    J Clin Invest; 2002 Aug; 110(4):499-504. PubMed ID: 12189244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
    Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
    J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
    Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement is an essential component of the immune response to adeno-associated virus vectors.
    Zaiss AK; Cotter MJ; White LR; Clark SA; Wong NC; Holers VM; Bartlett JS; Muruve DA
    J Virol; 2008 Mar; 82(6):2727-40. PubMed ID: 18199646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of PEGylated recombinant adeno-associated viruses for gene transfer.
    Le HT; Yu QC; Wilson JM; Croyle MA
    J Control Release; 2005 Nov; 108(1):161-77. PubMed ID: 16125817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In utero lung gene transfer using adeno-associated viral and lentiviral vectors in mice.
    Joyeux L; Danzer E; Limberis MP; Zoltick PW; Radu A; Flake AW; Davey MG
    Hum Gene Ther Methods; 2014 Jun; 25(3):197-205. PubMed ID: 24660751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
    Rivière C; Danos O; Douar AM
    Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy.
    Machen J; Bertera S; Chang Y; Bottino R; Balamurugan AN; Robbins PD; Trucco M; Giannoukakis N
    Gene Ther; 2004 Oct; 11(20):1506-14. PubMed ID: 15229635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
    Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE
    Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.